跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LONSURF - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LONSURF
Authorized
STANDARD
LONSURF
taiho pharma canada, inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
74c286eee97bba0c
Company
taiho pharma canada, inc.
Type
Standard
Approval Details
Approval Id
74c286eee97bba0c
Drug Approval Canada Name
LONSURF
Product Name
LONSURF
Status
Marketed
Status Date
2018-03-22
Original Market Date
2018-03-22
Din
02472112
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BC59 TRIFLURIDINE, COMBINATIONS
Atc Name
l 01 bc 59
Aig Number
0259910002
Company Name
taiho pharma canada, inc.
Company Address
503, 2010 Winston Park Drive, Oakville, Ontario, Canada, L6H 5R7
Active Ingredients
TRIFLURIDINE
20 MG
TIPIRACIL (TIPIRACIL HYDROCHLORIDE)
8.19 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
74c286eee97bba0c
Type
Standard
Back to Health Canada Approvals